Anti-Smoking Messages for Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
\<p\>The goal of this clinical trial is to learn how exposure to anti-smoking social media messages affects quitting-related behaviors. Eligible participants will be adults aged 21 or older who have used menthol cigarettes on at least 4 days during the past 30 days.\</p\> \<br\> \<p\>The main question this study aims to answer is: Does exposure to anti-smoking messages (in the context of a discrete choice experiment \[DCE\] with eye-tracking study) increase quitting-related behaviors over the following 2 weeks?\</p\> \<br\> \<p\>Participants will be randomly assigned to view the messages either immediately or after a 2-week waiting period, allowing researchers to compare quitting-related behaviors between the two groups. The primary outcome is whether participants report making a quit attempt in the 2 weeks following randomization.\</p\> \<br\> \<p\>Participants will:\</p\> \<ul\> \<li\>Complete eligibility screening and baseline questions about demographics and tobacco use.\</li\> \<li\>Be randomly assigned to view the messages immediately or after a 2-week waiting period.\</li\> \<li\>Attend a 1-hour in-person study visit at Georgia State University or the University of California, Santa Barbara.\</li\> \<li\>View 64 anti-smoking social media messages presented in 16 choice sets while their eye movements and pupil dilation are measured using a screen-based eye-tracking device.\</li\> \<li\>Select which messages most attract their attention, which they would be most likely to share, and which would most motivate them to quit smoking.\</li\> \<li\>Complete questions about quitting-related behaviors either during the study visit (waitlist control condition) or through an online questionnaire 2 weeks later (immediate condition).\</li\> \</ul\>
Are You a Good Fit for This Trial?
This trial is for adults aged 21 or older who smoke menthol cigarettes at least once a week and can attend an in-person visit. Participants must speak, read, and write English. People with certain eye conditions or special glasses that interfere with eye-tracking can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Waitlist Control
Participants wait 2 weeks before attending an in-person visit to answer questions about quitting-related behaviors and complete the DCE/eye-tracking study
Immediate Condition
Participants complete the in-person DCE/eye-tracking study visit immediately after randomization and then complete an online questionnaire assessing quitting-related behaviors 2 weeks later
Follow-up
Participants are monitored for quitting-related behaviors and intentions to quit smoking
What Are the Treatments Tested in This Trial?
Interventions
- Message Exposure via Discrete Choice Experiment
Trial Overview
The study tests whether seeing anti-smoking social media messages affects quit attempts among menthol cigarette smokers. Participants are randomly assigned to view these messages either right away or after two weeks while their eye movements are tracked.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants complete the in-person discrete choice experiment (DCE) with eye-tracking study visit immediately after randomization. During this visit, participants view 64 anti-smoking social media messages presented in 16 choice sets while their eye movements are recorded. Participants then complete an online questionnaire assessing quitting-related behaviors 2 weeks later.
Participants wait 2 weeks following randomization. At the start of an in-person visit conducted at the end of this waiting period, participants answer questions about quitting-related behaviors covering the preceding 2-week waiting period. Participants then complete the discrete choice experiment (DCE) with eye-tracking study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgia State University
Lead Sponsor
University of California, Santa Barbara
Collaborator
National Cancer Institute (NCI)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.